In the week commencing 13 December, the number of flu cases (caused by the influenza virus) detected in the WHO European Region was above what we would normally expect to find in the population for the second week in a row, which indicates the so-called flu season epidemic has started.
European Antibiotic Awareness Day (EAAD) is a European health initiative coordinated by ECDC. It provides a platform and support for national campaigns on the prudent use of antibiotics in the EU/EEA and is marked each year across Europe on 18 November. Due to the COVID-19 pandemic, EAAD will this year consist of a entirely digital campaign.
The Flu Awareness Campaign is marked across the WHO European Region every year in October. It aims to raise awareness of the importance of vaccination for people’s health and well-being and to increase the uptake of seasonal influenza vaccination of people with underlying risk factors.
Although the overall number of influenza detections in the majority of EU/EEA countries is still low, indications show that influenza circulation is above the seasonal threshold in Croatia, which is unusually early. The main reported subtype among the cases recorded in EU/EEA during the past month is A(H3N2), which disproportionally affects older people, and is associated with lower vaccine effectiveness. This is a sign that the upcoming influenza season could be severe for elderly people, and that influenza patterns may vary between countries in terms of timing.
On 26 July ECDC published the Rapid Risk Assessment COVID-19 outbreaks in long-term care facilities in the EU/EEA in the context of current vaccine coverage, following several outbreaks that occurred in these settings during the past six months in several EU/EEA countries, resulting in some cases of severe disease and deaths.
Each year on 5 May, the “SAVE LIVES: Clean Your Hands” campaign takes place as part of a major global effort led by the World Health Organization to mobilise people around the world to increase adherence to hand hygiene in all healthcare settings, thus protecting healthcare workers and patients from healthcare-associated infections caused by various pathogens.
Based on a systematic literature review, ECDC assessed the efficacy, effectiveness and safety of newer and enhanced inactivated seasonal influenza (flu) vaccines among those 18 years or older. These assessed are MF59® adjuvanted, cell-based, high-dose, and recombinant haemagglutinin influenza vaccines.